MarketBeat currently tracks 13 Hold ratings, four Buys, and one Sell
These agents have transformed the management of both type 2 diabetes and obesity, offering benefits beyond glycemic control
"Regional Variation of and Association of US Birthplace With Vitiligo Extent"
The idea that these popular medications might keep cancer at bay is receiving nationwide attention but its too early to suggest that anyone should start taking GLP-1s solely for that purpose, said Dan Mulkerin, MD, medical director for University of Rochester Medicines Wilmot Cancer Institute
We are confident that the expansion of Wegovy to a pill will help patients who may have not sought or accepted treatment before," said Dave Moore, executive vice president, US Operations at Novo Nordisk